{"id":"NCT00282984","sponsor":"Pfizer","briefTitle":"Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking","officialTitle":"A 12-Week, Double-Blind, Placebo-Controlled, Multicenter Study With A 40 Week Follow Up Evaluating the Safety and Efficacy of Varenicline Tartrate 1 Milligram (Mg) Twice Daily (BID) for Smoking Cessation in Subjects With Cardiovascular Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2007-11","completion":"2008-08","firstPosted":"2006-01-27","resultsPosted":"2009-04-29","lastUpdate":"2017-04-05"},"enrollment":714,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Smoking Cessation"],"interventions":[{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"Varenicline","otherNames":["Chantix, Champix"]}],"arms":[{"label":"placebo","type":"PLACEBO_COMPARATOR"},{"label":"varenicline","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to determine whether or not varenicline will help people with cardiovascular disease quit smoking and to confirm it is safe in these patients.","primaryOutcome":{"measure":"Number of Responders With Carbon Monoxide (CO) Confirmed 4-week Continuous Quit Rate (CQR) for Last 4 Weeks of Treatment (Trtmt)","timeFrame":"weeks 9 through 12","effectByArm":[{"arm":"Varenicline (Var)","deltaMin":167,"sd":null},{"arm":"Placebo (Pbo)","deltaMin":50,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"35 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":39,"countries":["United States","Argentina","Australia","Brazil","Canada","Czechia","Denmark","France","Germany","Greece","Mexico","Netherlands","South Korea","Taiwan","United Kingdom"]},"refs":{"pmids":["37142273","20048210"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A3051049&StudyName=Effectiveness%20and%20Safety%20of%20Varenicline%20in%20Smokers%20with%20Cardiovascular%20Disease%20Who%20Wish%20to%20Quit%20Smoking"]},"adverseEventsSummary":{"seriousAny":{"events":23},"commonTop":["Nausea","Headache","Insomnia","Nasopharyngitis","Diarrhoea"]}}